#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    IgA nephropathy Transient ischaemic attack Hyperphagia Ornithine transcarbamoylase deficiency Loeys-Dietz syndrome T-cell type acute leukaemia Pulmonary alveolar haemorrhage Univentricular heart Cutaneous T-cell lymphoma Angiosarcoma Hepatocellular carcinoma Rhabdoid tumour Primary mediastinal large B-cell lymphoma Propionic acidaemia Synovial sarcoma More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Treatment Glycogen storage disease type I – Treatment Gaucher’s disease type I – Treatment Immunodeficiency congenital – Basic Information Optic glioma Haemophilia B with anti factor IX – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Prader-Willi syndrome – Trials in Disease Langerhans’ cell histiocytosis – Treatment Rett syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Midomafetamine Hydrochloride Darunavir Vaborbactam Diclofenac Pegargiminase Avatrombopag Nizaracianine Triflutate Vericiguat Telisotuzumab Vedotin Oxygen Ampreloxetine Cortisone Acetate Alendronate Sodium Monohydrate Lonapegsomatropin Piperacillin Sodium Fludrocortisone Gs-4182 Cyclophosphamide A/(H3N2)-LIKE VIRUS ANTIGEN Tipiracil Hydrochloride More therapies…

    Learn about Your Condition

    Glomerulonephritis acute Infantile spasms Procedural headache Phenylketonuria Inborn error of metabolism Mitochondrial DNA depletion Actinic keratosis Ocular lymphoma Malignant neoplasm of choroid Dizziness Meniscus operation Gastrooesophageal cancer Hypothyroidism Extraskeletal ossification Corneal graft rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Insomnia

  • Study of tasimelteon compared to placebo for treating insomnia in children

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tasimelteon
    Germany Poland

  • Study of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    • Depression
    Investigated Drugs:
    • Melatonin
    France

  • Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Schizoaffective disorder
    • Insomnia
    Investigated Drugs:
    • Melatonin
    • Quetiapine
    Denmark

  • Study on Daridorexant’s Effect on Cognitive Performance in Patients with Chronic Insomnia Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Daridorexant
    Italy

  • Study on the Effects of Estradiol, Progesterone, and Online Sleep Therapy for Insomnia and Menopausal Symptoms in Perimenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Insomnia
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands

  • Study of Daridorexant for Treating Insomnia in Patients with Mild Cognitive Impairment and Mild to Moderate Alzheimer’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Daridorexant
    France
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!